Abbott Laboratories Gains Access to Expanded European Market with Navitor System

A significant regulatory milestone in Europe has positioned Abbott Laboratories for accelerated growth within its structural heart business. The medical device giant’s Navitor transcatheter aortic valve implantation (TAVI) system recently received expanded approval from European authorities, dramatically increasing its potential patient population and opening access to a substantially larger market.

European Read more...

@ boerse-global.de

Hol dir den Wissensvorsprung der Profis. Seit 2005 liefert der Börsenbrief trading-notes verlässliche Trading-Empfehlungen – dreimal die Woche, direkt in dein Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr.
Jetzt anmelden.